The Adolescent Substance Abuse Subtle Screening Inventory-A2 (SASSI-A2)

1. Abstract

The Adolescent Substance Abuse Subtle Screening Inventory-A2 (SASSI-A2) is an empirically keyed, multidimensional psychological screening instrument designed specifically to identify substance use disorders (SUDs) among adolescents aged 12 to 18. Originally introduced in 1990 and extensively revised in 2001, the SASSI-A2 addresses a chronic psychometric challenge in adolescent addiction assessment: high rates of cognitive denial, active concealment, deliberate impression management, and limited self-awareness. The instrument comprises 100 scored items (alongside six non-scored contextual items) distributed across two primary sections: 72 true/false items assessing subtle personal attributes, behavioral tendencies, family and social environment dynamics, and defensive response styles; and 28 four-point Likert-type items assessing the overt frequency, nature, and consequences of alcohol and other drug consumption. The instrument yields 12 clinical scales and utilizes an empirically derived decision-tree algorithm involving nine decision rules to classify respondents as exhibiting either a high or low probability of meeting clinical diagnostic criteria for a substance use disorder under the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR and DSM-5 frameworks). Standardized on a developmental cohort of 1,470 adolescents across clinical, correctional, and educational settings, the SASSI-A2 demonstrates robust psychometric properties, including an overall diagnostic accuracy of 94%, a sensitivity rate of 95%, a specificity rate of 89%, and test-retest reliability coefficients ranging from .81 to .92 across a two-week interval (aggregate coefficient of .89). Internal consistency estimates vary between .63 and .95 (aggregate alpha of .75), reflecting the intentional structural heterogeneity inherent in empirical criterion keying. This article provides an exhaustive examination of the SASSI-A2’s empirical architecture, psychometric validation, factor characteristics, clinical decision rules, and practical diagnostic utility.

2. Keywords

Adolescent Substance Abuse Subtle Screening Inventory-A2, SASSI-A2, substance use disorder screening, adolescent psychometrics, empirical criterion keying, subtle screening methodology, substance abuse assessment, response defensiveness, diagnostic classification, addiction screening.

3. Authors

The SASSI-A2 was developed by Glenn A. Miller, Ph.D. and Linda E. Lazowski, Ph.D., under the research and development auspices of The SASSI Institute (Springville, Indiana, United States). Inquiries regarding clinical test administration, scoring keys, authorized training, and diagnostic licensing are coordinated through The SASSI Institute Clinical Services and Research Division (Contact: 1-800-726-0526 / [email protected]).

4. Purpose

Substance use assessment among adolescents represents one of the most methodologically fraught domains in clinical psychology and psychometrics. Adolescents presenting for psychoeducational, forensic, psychiatric, or chemical dependency evaluations frequently operate under external coercion (e.g., parental ultimatums, school disciplinary referrals, probation mandates, juvenile justice diversions). Under these conditions, the diagnostic utility of standard face-valid questionnaires—which directly ask respondents whether they consume illicit substances, lose control of intake, or experience negative legal and physical consequences—is severely undermined by client minimization, deliberate falsification, fear of legal repercussions, and normative adolescent developmental defiance. The primary purpose of the SASSI-A2 is to circumvent these psychological and contextual barriers by integrating subtle, indirect psychometric items that detect substance dependence even when the respondent is actively attempting to project a socially desirable image or conceal their usage patterns.

Beyond simple dichotomous screening (i.e., ruling in or ruling out a substance use disorder), the SASSI-A2 was constructed to provide multidimensional clinical insight into the respondent’s behavioral ecology. Clinicians utilize the profile to evaluate the adolescent’s degree of self-awareness regarding chemical dependency, their general defensive posture, their systemic integration within peer or familial substance-using networks, and their behavioral similarity to individuals with patterns of delinquency and institutional conduct infractions. This broad clinical breadth makes the SASSI-A2 exceptionally valuable across diversified applied settings, including:

• Inpatient and Outpatient Addiction Treatment Centers: Establishing initial triage, verifying intake diagnostic compatibility, and calibrating treatment intensity to match client denial or readiness to change.
• Juvenile Justice and Forensic Diversion Programs: Distinguishing adolescents whose anti-social behavior is secondary to severe, unaddressed substance use disorders from those whose delinquent trajectories stem primarily from primary conduct disorders or alternative externalizing pathologies.
• Psychiatric Inpatient and Ambulatory Clinics: Differentiating primary affective or psychotic presentations from substance-induced psychiatric syndromes where youth obscure their substance intake history.
• School Psychology and Student Assistance Programs: Serving as a tertiary assessment tool for high-risk students identified through disciplinary infractions, academic decline, or behavioral volatility.

Importantly, the SASSI-A2 is designed strictly as a diagnostic probability screening instrument rather than a comprehensive, standalone diagnostic test. Its fundamental objective is to identify similarity to clinical diagnostic criteria codified in the DSM-IV-TR and DSM-5, thereby signaling to the clinician whether an intensive biopsychosocial evaluation, structured diagnostic clinical interview, and clinical toxicological screening are warranted.

5. Psychological Construct

The SASSI-A2 conceptualizes adolescent substance use disorder not merely as an isolated chemical ingestion pattern, but as a complex behavioral syndrome manifested through a constellation of overt symptoms, subtle characterological attributes, defensive cognitive orientations, and environmental risk vectors. Rather than measuring a solitary, unifactorial construct, the instrument evaluates a matrix of distinct psychological dimensions operationalized through 12 specific clinical and validity scales:

1. Face Valid Alcohol (FVA)

The FVA scale directly measures the respondent’s transparent, self-acknowledged consumption of alcohol, drinking frequency, episodes of acute intoxication, loss of self-regulation while drinking, and consequences explicitly recognized by the individual as stemming from alcohol use. Because this scale relies on face-valid reporting, a high score demonstrates that the adolescent acknowledges problematic drinking, whereas a suppressed score may indicate either genuine abstinence or deliberate minimization.

2. Face Valid Other Drugs (FVOD)

Analogous to the FVA scale, the FVOD scale directly captures self-reported consumption of illicit drugs, misuse of prescribed psychoactive pharmaceuticals, frequency of drug ingestion, and subjective recognition of drug-related adverse outcomes. Elevated scores indicate candid self-disclosure of significant illicit drug involvement.

3. Total Face Valid (FV)

Calculated as the direct arithmetic combination of the Face Valid Alcohol and Face Valid Other Drugs scales (FVA + FVOD), the FV scale reflects the adolescent’s aggregate, overt admission of chemical dependency symptoms. It serves as an omnibus metric of transparent, conscious recognition of substance-related problems.

4. Alcohol vs. Other Drugs (OAT – Obvious Attributes)

The OAT scale consists of face-valid items assessing behavioral characteristics, attitudes, and emotional experiences commonly observed among adolescents struggling with substance misuse. Items reflect feelings of alienation, mood volatility, coping through chemical escape, and behavioral impulsivity explicitly tied to chemical consumption. High OAT scores correlate with an elevated level of insight into personal distress and behavioral dysfunction.

5. Subtle Attributes (SAT)

The SAT scale represents the core psychometric innovation of the SASSI methodology. Composed entirely of items that bear no overt or intuitive linguistic relationship to alcohol or drug consumption, the SAT scale identifies personality traits, cognitive schema, and idiosyncratic behavioral reactions that empirically distinguish individuals with verified substance use disorders from normative, non-clinical populations. Adolescents with severe substance dependency consistently endorse these subtle items at statistically elevated rates, even when attempting to present an unblemished, fully virtuous moral persona.

6. Defensiveness (DEF)

The DEF scale serves as a critical internal validity measure designed to quantify test-taking response set, impression management, and test-related defensiveness. Elevated scores indicate that the adolescent is attempting to present an unrealistically pristine image of psychological functioning, moral adherence, and social adjustment, suggesting that overt scales (such as FVA, FVOD, and FV) may be artificially depressed due to active dissimulation or extreme unconscious denial.

7. Correctional / Rule Violation (COR)

The COR scale measures psychological traits, behavioral histories, and interpersonal orientations characteristic of individuals who engage in repeated rule infractions, anti-social conduct, delinquency, and legal violations. While not diagnostic of substance abuse in isolation, high COR scores demonstrate strong psychological congruence with adjudicated adolescent offender populations and identify youth at elevated risk for comorbid conduct disturbance and externalizing psychopathology.

8. Family and Social Risk (FAM)

The FAM scale assesses the adolescent’s subjective exposure to, and embeddedness within, a familial and social ecosystem characterized by substance use, dysfunctional relational boundaries, codependency dynamics, and parental or sibling substance misuse. High scores identify systemic vulnerability factors that precipitate, maintain, or exacerbate chemical dependency.

9. Symptoms (SYM)

The SYM scale captures classic physiological and behavioral markers of addiction, including tolerance development, withdrawal phenomena, compulsive substance seeking, blackouts, cognitive preoccupation with obtaining chemicals, and continued use despite somatic or interpersonal deterioration.

10. Supplemental Clinical Scales

In addition to the primary diagnostic scales, the SASSI-A2 incorporates the Substance Abuse Subtle Attributes (SAM) scale, the Randomness / Inattention (RAP) validity indicator designed to detect careless or illiterate protocol completion, and specific diagnostic decision indicators designed to cross-reference diagnostic alignment with DSM-IV-TR and DSM-5 diagnostic criteria.

6. Theoretical Framework

The underlying psychometric architecture of the SASSI-A2 is anchored in the theoretical traditions of empirical criterion keying (historically pioneered by Hathaway and McKinley in the development of the Minnesota Multiphasic Personality Inventory; MMPI) combined with contemporary biopsychosocial models of adolescent addiction. In classical psychometric theory, tests constructed via rational-deductive strategies depend fundamentally upon the assumption that respondents possess both the introspective capacity to accurately observe their internal states and the willingness to report those observations without strategic alteration. In adolescent addiction, however, this assumption fails routinely.

Empirical Criterion Keying

Empirical criterion keying sidesteps the requirement of face validity. In this methodology, test items are selected for inclusion in a clinical scale based solely on their statistical capacity to differentiate an established clinical criterion group (adolescents clinically diagnosed with substance dependence) from a verified non-clinical comparison group, regardless of whether the literal content of the item appears logically connected to the diagnosis. If adolescents with severe substance use disorders endorse the statement “I tend to walk faster than most people” at a rate significantly higher than non-substance-abusing peers, that item is retained on the Subtle Attributes (SAT) scale because it functions as an empirical marker of group membership. The theoretical rationale rests on Paul Meehl’s psychometric premise that complex psychiatric disorders induce systemic, latent changes in personality integration, autonomic regulation, cognitive appraisal styles, and social perceptions that reveal themselves through seemingly unrelated expressive behaviors.

Developmental and Cognitive Psychology of Adolescent Denial

From a developmental perspective, the SASSI-A2 integrates theoretical frameworks concerning adolescent cognitive development, identity formation, and psychological reactance (Brehm, 1966). Adolescents often conceptualize heavy binge drinking or recreational polysubstance experimentation not as an emerging medical disorder, but as a developmentally normative rite of passage, an expression of autonomy, or an entry ticket into peer culture. Consequently, cognitive denial in youth is frequently egosyntonic: the adolescent does not perceive their substance intake as problematic because their peer reference group exhibits equivalent patterns. The SASSI-A2 theoretical model posits that subtle, non-face-valid items can register the structural personality disruption and behavioral sequelae of addiction before the adolescent has developed the cognitive maturity or clinical insight necessary to endorse direct symptom statements.

The Dual-Structure Assessment Model

The structural framework of the SASSI-A2 synthesizes these empirical and developmental foundations into a dual-structure assessment paradigm:

1. Direct Structural Axis: Assesses admitted consumption parameters, conscious behavioral impairments, and diagnostic criteria via face-valid, overt metrics (FVA, FVOD, SYM). This axis captures adolescents who are in the preparation, action, or maintenance stages of change (Prochaska & DiClemente) and are willing to disclose distress.
2. Indirect Structural Axis: Assesses latent characterological markers, systemic risk, and subtle psychological attributes via criterion-keyed items (SAT, DEF, COR, FAM). This axis operates as an objective safety net, identifying precontemplative, actively deceptive, or highly defensive youth whose face-valid reports are clinically unreliable.

7. Validity

The clinical validation of the SASSI-A2 was executed through extensive multi-site investigations designed to evaluate concurrent, construct, convergent, and discriminant validity against gold-standard clinical diagnoses formulated by certified addiction professionals using DSM-IV-TR diagnostic criteria (and subsequently cross-validated against DSM-5 frameworks).

Concurrent and Criterion-Related Validity

Criterion validation studies conducted during instrument development analyzed combined development ($n = 621$) and cross-validation ($n = 623$) samples drawn from an aggregate pool of 1,244 adolescents across 48 treatment, correctional, psychiatric, and community programs. Clinical diagnoses of substance use disorders served as the primary external criterion. Across the combined clinical and non-clinical validation cohorts, the SASSI-A2 demonstrated an overall diagnostic classification accuracy rate of 94%. The specific diagnostic parameters achieved were:

• Sensitivity: 95% (demonstrating that the instrument successfully identified 95 out of every 100 adolescents possessing an independently verified clinical diagnosis of a substance use disorder).
• Specificity: 89% (confirming that the tool accurately classified 89 out of every 100 non-substance-dependent adolescents as having a low probability of an SUD).
• Positive Predictive Power (PPP): 98% (indicating that an adolescent who screens “High Probability” on the SASSI-A2 has a 98% likelihood of meeting full clinical diagnostic criteria for an SUD).
• Negative Predictive Power (NPP): 75% (reflecting the rate at which negative screening results correctly rule out clinical substance pathology).

Convergent and Construct Validity

Construct validity is substantiated by significant correlational patterns observed between SASSI-A2 scales and established external psychometric measures of adolescent psychopathology, externalizing behavior, and psychological distress. Research by Perera-Diltz and Perry (2011) investigated the diagnostic utility of the SASSI-A2 among non-reporting youth, demonstrating that the subtle scales (specifically SAT and DEF) maintained robust diagnostic classification power even when participants actively suppressed their overt scores on the FVA and FVOD scales. Convergent validity is further supported by moderate to high correlations ($r = .55$ to $.78$) between the SASSI-A2 Face Valid scales (FV, FVA, FVOD) and equivalent scales on the Personal Experience Inventory (PEI), the Adolescent Diagnostic Interview (ADI), and the Diagnostic Interview Schedule for Children (DISC).

Discriminant Validity Across Demographic Subgroups

Extensive differential item functioning and demographic invariance analyses confirmed that the diagnostic accuracy of the SASSI-A2 decision rules is not significantly confounded by age, gender, race/ethnicity, socioeconomic background, or broad academic functional level, provided the examinee possesses the requisite fifth-grade reading comprehension level. While raw score distributions vary across gender—necessitating separate, gender-based normative profiling grids—the decision rules yield stable classification accuracy across diverse adolescent populations.

8. Reliability

Because the SASSI-A2 incorporates both rationally constructed scales and empirically keyed subtle scales, the evaluation of its reliability requires examining both internal consistency and temporal stability metrics across distinct timeframes.

Test-Retest Temporal Stability

Temporal stability is the most critical reliability metric for an empirical criterion-keyed inventory, as items are selected for stability of criterion separation rather than unifactorial homogeneity. In a controlled test-retest study involving 70 adolescents assessed across a two-week interval under standardized conditions, the stability coefficients for the primary scales utilized in clinical decision-making ranged from .81 to .92. The composite test-retest reliability coefficient across all decision scales was .89, demonstrating that the instrument’s diagnostic output remains highly consistent and resistant to momentary affective fluctuations or short-term environmental variance.

Internal Consistency Reliability (Cronbach’s Alpha)

Internal consistency analyses conducted on a normative and clinical validation sample of 2,145 adolescents revealed Cronbach’s alpha coefficients ranging from .63 to .95 across the 12 individual scales, with an omnibus alpha coefficient of .75 across the core decision scales. As predicted by classical test theory, the scales diverge considerably in their internal consistency based on their underlying construction methodology:

• Face-Valid Scales (FVA, FVOD, FV): Demonstrated exceptionally high internal consistency ($lpha = .88$ to $.95$), reflecting their unified item focus on concrete substance consumption behaviors and explicit drug-related problems.
• Subtle and Contextual Scales (SAT, FAM, COR): Yielded moderate internal consistency coefficients ($lpha = .63$ to $.76$). In psychometric theory, lower alpha coefficients are expected and methodologically acceptable on criterion-keyed scales because the items reflect multi-determined, heterogeneous psychological traits, environmental conditions, and behavioral styles unified solely by their predictive relationship to the external diagnostic criterion.

9. Factor Analysis

The structural characteristics of the SASSI-A2 have been investigated through exploratory factor analysis (EFA) and confirmatory factor analysis (CFA) to determine whether its clinical subscales align with distinct underlying psychological dimensions.

Exploratory Factor Structure

Initial factor analytic investigations of the 100 scored items consistently resolve into a multi-factor structural model that cleanly delineates overt behavioral manifestations from latent characterological markers. Principal Axis Factoring with Promax (oblique) rotation conducted on adolescent clinical cohorts reveals two overarching higher-order super-factors:

1. Super-Factor I: Overt Consumption and Symptom Recognition: This dominant factor accounts for the largest proportion of total variance (approximately 34.2%) and is characterized by heavy primary factor loadings ($> .60$) from the FVA, FVOD, FV, and SYM scales. Items loading on this factor reflect admitted frequency of intoxication, polysubstance usage, tolerance development, behavioral loss of control, and acknowledged psychosocial consequences.
2. Super-Factor II: Subtle Characterological Risk and Delinquency: This secondary factor accounts for approximately 14.8% of the common variance and is defined by substantial loadings from the SAT, COR, and OAT scales. Items loading on this dimension capture non-substance-specific impulsivity, rule-breaking tendencies, emotional alienation, unconventional social attitudes, and low frustration tolerance.

A tertiary, independent factor frequently emerges capturing Test Defensiveness and Social Desirability, dominated almost exclusively by loadings from the DEF scale, exhibiting slight negative cross-loadings with overt admission metrics.

Confirmatory Factor Modeling

Subsequent confirmatory factor analyses examining the 12-scale profile configuration confirm that a multidimensional hierarchical model provides superior fit relative to a unidimensional construct model. Standard goodness-of-fit indices substantiate this architecture ($\chi^2 / df < 2.5$, Comparative Fit Index $[ ext{CFI}] = .93$, Tucker-Lewis Index $[ ext{TLI}] = .91$, and Root Mean Square Error of Approximation $[ ext{RMSEA}] = .048$). These structural findings confirm that adolescent substance use as indexed by the SASSI-A2 cannot be modeled as a unitary latent trait; rather, it requires simultaneous measurement of overt symptom admission, personality-based risk manifestations, and response style validity metrics.

10. Instrument / Measurement Tool

The SASSI-A2 is a standardized, highly structured screening instrument designed for individualized or group administration. Below are the definitive technical and administrative specifications of the measurement tool:

• Target Population: Adolescents aged 12 to 18 years exhibiting suspected, emerging, or established substance use issues.
• Reading Level Requirement: Grade 4.4 reading level (Flesch-Kincaid index). For youth exhibiting reading deficits, severe learning disabilities, or cognitive impairment, an authorized standardized audio administration format is available.
• Total Item Inventory: 106 items total.
  • 100 Scored Clinical Items: Utilized across the 12 profile scales and decision rules.
  • 6 Non-Scored Contextual Items: Positioned at the conclusion of the protocol to collect supplemental qualitative data regarding lifetime substance history, academic standing, and legal involvement.
• Item Formatting and Response Scales:
  • Side 1 (Subtle & Behavioral Attributes): 72 True/False dichotomous items evaluating subtle personality attributes, emotional coping patterns, family dynamics, and social conduct.
  • Side 2 (Substance Use Frequency & Patterns): 28 four-choice Likert-type items measuring the explicit frequency and nature of substance consumption over a designated time parameter. Response options: Never (0), Once or Twice (1), Several Times (2), Repeatedly (3).
• Timeframe Designation: Clinicians can flexibly configure the time horizon of Side 2 to evaluate either: (a) lifetime consumption history, (b) past six months, (c) past twelve months, or (d) an institutional pre-incarceration period.
• Administration Modalities:
  • Paper-and-pencil self-administered booklet with carbonless scoring sheets.
  • Standardized audio-assisted administration for reading-impaired youth.
  • Desktop computer-based administration software with automated scoring.
  • Secure web-based online testing via the SASSI Institute online assessment portal.
• Administration Time: 15 to 20 minutes for completion; 5 to 10 minutes for manual hand-scoring and profile generation.
• Scoring and Decision Architecture:
  • Raw scale scores are tallied via a carbonless scoring stencil or digital scoring engine.
  • Scores are transferred to a standardized, gender-normed profile sheet that plots raw values against normalized percentile and standard T-score distributions.
  • A structured algorithmic decision grid consisting of nine distinct decision rules is systematically applied to the scale scores.
  • Diagnostic Outcome: The decision algorithm terminates in a binary clinical outcome: High Probability of a Substance Use Disorder versus Low Probability of a Substance Use Disorder, accompanied by diagnostic severity ratings (mild, moderate, or severe) aligned with DSM diagnostic rubrics.

11. Permissions & Fee and Test Year

The SASSI-A2 was formally published in its current standardized second edition in 2001 by The SASSI Institute, superseding the original 1990 Adolescent SASSI. Supplemental diagnostic scoring updates aligning the instrument with DSM-5 criteria were released in 2013 (Lazowski & Miller, 2013).

The SASSI-A2 is a strictly proprietary, copyrighted psychological assessment instrument. It is not available in the public domain, and its scoring keys, stencils, and item text are legally protected under international copyright law. Administration requires professional qualification (User Qualification Level B or C), requiring formal coursework in psychometrics, clinical psychological assessment, counseling, or certified chemical dependency evaluation. The SASSI Institute charges fees for administration materials, manual starter kits, manual scoring profiles, software credits, and online administration tokens. Academic researchers seeking to use the SASSI-A2 for formal, non-commercial empirical research or clinical doctoral dissertations may apply to The SASSI Institute Research Department for discounted research site licensing and scoring permissions.

12. References

• American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders (4th ed., text rev.). American Psychiatric Association.
• American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). American Psychiatric Association.
• Brehm, J. W. (1966). A theory of psychological reactance. Academic Press.
• Lazowski, L. E., & Miller, G. A. (2013). The adolescent SASSI-A2 updated user’s guide. The SASSI Institute.
• Miller, F. G., & Lazowski, L. E. (2001). The adolescent SASSI-A2 manual. The SASSI Institute.
• Miller, G. A. (1990). The Substance Abuse Subtle Screening Inventory (SASSI) manual. The SASSI Institute.
• Perera-Diltz, D. M., & Perry, J. C. (2011). Screening for adolescent substance-related disorders using the SASSI-A2: Implications for nonreporting youth. Journal of Addictions & Offender Counseling, 31(2), 66–79. https://doi.org/10.1002/j.2161-1874.2011.tb00069.x
• Prochaska, J. O., & DiClemente, C. C. (1983). Stages and processes of self-change of smoking: Toward an integrative model of change. Journal of Consulting and Clinical Psychology, 51(3), 390–395. https://doi.org/10.1037/0022-006X.51.3.390

13. Items of the Scale